Proteotype Diagnostics

Proteotype Diagnostics develops advanced multi-cancer early detection and personalized medicine tests. Their Enlighten™ test measures the body's response to tumor development, offering a potentially more powerful approach to early cancer detection than traditional methods. This innovative approach aims to revolutionize cancer diagnostics and improve patient outcomes.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: £1.5M

Date: 09-Oct-2024

Investors: National Institute for Health and Care Research (NIHR), Office for Life Sciences (OLS)

Markets: Healthtech, Diagnostics, Oncology, Drug Discovery, Laboratory Services (Healthcare), Life Sciences

HQ: Cambridge, England, United Kingdom

Founded: 2019

Website: https://www.proteotype.com/

LinkedIn: https://www.linkedin.com/company/proteotype

Twitter:

Instagram: